Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 39.00M | $ 34.00M | $ 68.20M | $ 4.70M | $ 39.80M |
Total Assets | $ 1.07B | $ 1.06B | $ 1.00B | $ 997.50M | $ 1.02B |
Total Debt | $ 207.10M | $ 207.80M | $ 208.50M | $ 253.40M | $ 243.60M |
Net Debt | $ 168.10M | $ 173.80M | $ 140.30M | $ 248.70M | $ 203.80M |
Total Liabilities | $ 361.40M | $ 362.20M | $ 350.60M | $ 352.10M | $ 369.80M |
Stockholders Equity | $ 708.10M | $ 699.70M | $ 652.80M | $ 645.40M | $ 648.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |